This clinical trial will determine if Besifloxacin Ophthalmic Solution is an effective treatment for bacterial conjunctivitis.
Click here to access this third-party resource:
Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis
Study Type: Interventional
Age/Gender Requirements: 1 year+ (male/female)
Sponsor: Bausch & Lomb, Inc.
Purpose: This study will evaluate “the clinical and microbial efficacy of besifloxacin ophthalmic suspension compared with vehicle” for the treatment of bacterial conjunctivitis.